A follow-up study of Lorenzo’s Oil confirms that the Oil is effective in delaying the onset of adrenoleukodystrophy (ALD) in boys without symptoms who started the therapy under the age of six. Dr. Hugo Moser of Kennedy Krieger Institute in Baltimore, Maryland, said the results validate those of his earlier international study. The reliability of the results is enhanced by the fact that the original trial and the follow-up study, which used different statistical methods, led to similar conclusions. A further issue that may be addressed through longer follow-up of patients is whether Lorenzo’s Oil has the ability to not only delay but avoid completely the onset of childhood ALD.
Lorenzo’s Oil is also effective in slowing the progression of the disease in adults with adrenomyeloneuropathy (AMN). Dr. Wolfgang Köhler of Saxonian State Hospital Hubertusburg in Wermsdorf, Germany conducted a study of 50 AMN patients who took the oil for a mean period of 6.3 years: Overall, 84% were clinically better than what may have been expected on the basis of the natural course of the disease, while a subgroup of 48% remained stable or improved.
For more information on Lorenzo's Oil, visit The Myelin Project website at www.myelin.org